US Stem Cell Inc
U.S. Stem Cell, Inc. engages in the research, development, and commercialization of stem cell and regenerative treatments in the United States and internationally. The company develops MyoCell, an autologous muscle stem cell therapy which is preparing for phase II/III clinical trials for the treatment of heart damage in heart failure patients; MyoCell SDF-1, an autologous cell therapy which compl… Read more
US Stem Cell Inc (USRM) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of March 2023: 0.003x
Based on the latest financial reports, US Stem Cell Inc (USRM) has a cash flow conversion efficiency ratio of 0.003x as of March 2023.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-43.06K) by net assets ($-14.75 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
US Stem Cell Inc - Cash Flow Conversion Efficiency Trend (2004–2022)
This chart illustrates how US Stem Cell Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
US Stem Cell Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of US Stem Cell Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Gloo Holdings, Inc. Class A Common Stock
NASDAQ:GLOO
|
N/A |
|
Namkwang Engineering & Construction Co. Ltd.
KQ:001260
|
N/A |
|
Edel AG
HM:EDL
|
N/A |
|
Florence One Capital Inc.
V:FONC-P
|
-0.022x |
|
Sentia Asa
OL:SNTIA
|
-0.272x |
|
Aquarius Surgical Technologies Inc
PINK:AQQRF
|
0.008x |
|
Kwang Dong Pharmaceutical Co. Ltd.
KQ:009290
|
N/A |
|
RDOR3F
SA:RDOR3F
|
N/A |
Annual Cash Flow Conversion Efficiency for US Stem Cell Inc (2004–2022)
The table below shows the annual cash flow conversion efficiency of US Stem Cell Inc from 2004 to 2022.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2022-12-31 | $-14.75 Million | $-304.85K | 0.021x | -75.05% |
| 2021-12-31 | $-12.77 Million | $-1.06 Million | 0.083x | +100.38% |
| 2020-12-31 | $-11.58 Million | $-478.89K | 0.041x | -67.63% |
| 2019-12-31 | $-9.48 Million | $-1.21 Million | 0.128x | +245.93% |
| 2018-12-31 | $-6.88 Million | $602.47K | -0.088x | +49.52% |
| 2017-12-31 | $-7.10 Million | $1.23 Million | -0.173x | -1138.98% |
| 2016-12-31 | $-8.02 Million | $112.24K | -0.014x | -112.80% |
| 2015-12-31 | $-7.72 Million | $-844.69K | 0.109x | +7.50% |
| 2014-12-31 | $-10.89 Million | $-1.11 Million | 0.102x | -26.88% |
| 2013-12-31 | $-13.75 Million | $-1.91 Million | 0.139x | +85.47% |
| 2012-12-31 | $-14.60 Million | $-1.10 Million | 0.075x | -46.79% |
| 2011-12-31 | $-12.01 Million | $-1.69 Million | 0.141x | -10.53% |
| 2010-12-31 | $-12.02 Million | $-1.89 Million | 0.158x | +4.35% |
| 2009-12-31 | $-13.41 Million | $-2.03 Million | 0.151x | -80.41% |
| 2008-12-31 | $-14.24 Million | $-10.98 Million | 0.771x | -56.36% |
| 2007-12-31 | $-5.50 Million | $-9.73 Million | 1.767x | +197.30% |
| 2006-12-31 | $4.31 Million | $-7.83 Million | -1.816x | -44.49% |
| 2005-12-31 | $4.59 Million | $-5.77 Million | -1.257x | -146.92% |
| 2004-12-31 | $-1.86 Million | $-4.98 Million | 2.679x | -- |